Skip to content

A study to check how well Baljeevan Syrup works in boosting immunity in children between 4 and 9 years

A Clinical Study to Evaluate the Efficacy of Baljeevan Syrup as an Immunity Booster in Children aged 4-9 years old- An Open labelled, Double arm, Multi centric, Comparative, Post-Marketing Survillence Study (Phase IV) Clinical Study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093409
Enrollment
100
Registered
2025-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Rashtriya Shikshan Mandals Research Institute of Health Sciences and Management Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged 4 to 9 years old. 2.Clinically diagnosed with recurrent respiratory allergic disorders. 3. Parents/guardians willing to provide written informed consent for participation.

Exclusion criteria

Exclusion criteria: 1. Children below 4 years or above 9 years of age. 2.Known cases of congenital heart disease, chronic kidney disease, diabetes, or tuberculosis. 3.Known cases of systemic disorders. 4.Known cases of immunodeficiency disorders. 5.Currently undergoing steroid treatment or immunosuppressive therapy. 6.Participation in any other clinical study within 3 months prior to screening for the present study. 7.Other conditions, which in the opinion of the investigators, render the patient unsuitable for enrolment or could interfere with adherence to the study protocol. 8.Inability or unwillingness of the parent/guardian to adhere to the follow-up schedule or instructions.

Design outcomes

Primary

MeasureTime frame
1.Reduction in frequency of respiratory allergic episodes. Timepoint: Baseline, end of 6th month

Secondary

MeasureTime frame
1. Changes in immunological markers like IgE, IL6, IL10.Timepoint: Baseline, end of 6th month;2.Improvement in general Health parameters.Timepoint: Every Visit;3.Safety and tolerability of Baljeevan Syrup.Timepoint: Every Visit

Countries

India

Contacts

Public ContactDr Kalpana Dhuri

Dr D Y Patil Deemed to be University, School of Ayurveda, Nerul-Navi Mumbai

dhurikalpana34@gmail.com9321835616

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026